Tamoxifen, AI therapies linked to reduced risk for contralateral breast cancer in community health

(The JAMA Network Journals) In patients with invasive breast cancer treated in a general community health care setting, tamoxifen therapy was associated with reduced risk for contralateral breast cancer in the opposite breast and that risk progressively decreased as the duration of tamoxifen therapy increased, according to a new study published online by JAMA Oncology.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news